Dr. Prem Krishan Tambar, M.D Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 151 Buffalo Ave, Suite 210, Niagara Falls, NY 14303 Phone: 716-282-3310 Fax: 716-282-3346 |
News Archive
Incyte Corporation announced the presentation of final six-month clinical data from the dose ranging, placebo-controlled Phase IIa trial of its orally available janus kinase (JAK) inhibitor INCB28050 in patients with active rheumatoid arthritis (RA).
Using aspirin on a regular basis for 10 years or more during middle-to-old age could increase the risk for the developing incident age-related macular degeneration, indicate study results.
The U.S. Food and Drug Administration today announced a program aimed at facilitating the development of safer, more effective external defibrillators used to treat abnormal heart rhythms through improved design and manufacturing practices. External defibrillators are medical devices designed to diagnose life-threatening abnormal heart rhythms and treat them by delivering electrical energy to the heart to restore its normal rhythm.
Gilead Sciences, Inc. today announced that aztreonam for inhalation solution, an investigational product for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF), is scheduled to be reviewed by the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) on December 10, 2009.
› Verified 6 days ago